1. Academic Validation
  2. Tumor necrosis factor signaling

Tumor necrosis factor signaling

  • Cell Death Differ. 2003 Jan;10(1):45-65. doi: 10.1038/sj.cdd.4401189.
H Wajant 1 K Pfizenmaier P Scheurich
Affiliations

Affiliation

  • 1 Institute of Cell Biology and Immunology, University of Stuttgart, Allmandring, Germany. harald.wajant@po.uni-stuttgart.de
Abstract

A single mouse click on the topic tumor necrosis factor (TNF) in PubMed reveals about 50,000 articles providing one or the Other information about this pleiotropic cytokine or its relatives. This demonstrates the enormous scientific and clinical interest in elucidating the biology of a molecule (or rather a large family of molecules), which began now almost 30 years ago with the description of a cytokine able to exert antitumoral effects in mouse models. Although our understanding of the multiple functions of TNF in vivo and of the respective underlying mechanisms at a cellular and molecular level has made enormous progress since then, new aspects are steadily uncovered and it appears that still much needs to be learned before we can conclude that we have a full comprehension of TNF biology. This review shortly covers some general aspects of this fascinating molecule and then concentrates on the molecular mechanisms of TNF signal transduction. In particular, the multiple facets of crosstalk between the various signalling pathways engaged by TNF will be addressed.

Figures
Products